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Aim To evaluate the role of gray-scale and color duplex-
Doppler ultrasound (CDUS) in diagnosis of changes of 
hand joints and assessment of treatment efficacy in pa-
tients with rheumatoid arthritis (RA) by comparing qualita-
tive and quantitative US parameters with clinical and labo-
ratory indicators of disease activity.
Methods Ulnocarpal (UC), metacarpophalangeal (MCP), 
and proximal interphalangeal (PIP) joints in 30 patients 
with RA were examined by gray-scale and CDUS before and 
after six months of treatment. Morphologic and quantita-
tive Doppler findings (synovial thickness, effusion quantity, 
vascularization degree, resistance index, velocities) were 
compared with clinical indicators of disease progression: 
disease activity score (DAS 28), Health Assessment Ques-
tionnaire (HAQ), rheumatoid factor (RF), erythrocyte sedi-
mentation rate (ESR), and C reactive protein (CRP).
Results Clinical indicators changed significantly after 
treatment: ESR from 38.1 ± 22.4 mm/h to 27.8 ± 20.9 mm/h 
(P = 0.013), DAS 28 from 5.47 ± 1.56 to 3.87 ± 1.65 (P < 0.001), 
and HAQ from 1.26 ± 0.66 to 0.92 ± 0.74 (P = 0.030), indicat-
ing therapeutic effectiveness. In all MCP and UC joints we 
observed a significant change in at least one US parameter, 
in 6 out of 12 joints we observed a significant change in 
≥2 parameters, and in 2 UC joints we observed significant 
changes in ≥3 parameters. The new finding was that the 
cut-off values of resistance index of 0.40 at baseline and of 
0.55 after the treatment indicated the presence of active 
disease and the efficacy of treatment, respectively; also it 
was noticed that PIP joints can be omitted from examina-
tion protocol.
Conclusion Gray scale and CDUS are useful in diagnosis of 
changes in UC and MCP joints of patients with RA and in 
monitoring the treatment efficacy.
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Rheumatoid arthritis (RA) is a chronic systemic inflamma-
tory disease of unknown etiology, which primarily affects 
the synovia; persisting synovitis of symmetric peripheral 
joints can lead to structural damage of cartilage, bones, 
tendons, and ligaments (1). The standard modality used to 
estimate joint destruction in patients with RA is conven-
tional radiography (CR), although its sensitivity to detect 
early erosions is relatively low and it cannot demonstrate 
the inflamed synovia (2-4). The classic radiographic signs 
of RA are osteoporosis, bone erosions, and joint space 
narrowing. The presence of bone erosions has consider-
able implications for the treatment and prognosis (3). For 
the correct diagnosis of RA it is necessary to analyze the 
changes on joints of hands and feet, and radiographic fol-
low up of early polyarthritis is the integral part of patients’ 
treatment. Regression of bone erosions seldom occurs in 
patients who receive treatment and cannot be used as an 
indicator of treatment efficacy, and CR is not an adequate 
method to evaluate treatment success (2,4).
Early changes can be revealed much better by scintigraphy 
and magnetic resonance imaging (MRI); contrast-enhanced 
MRI enables early detection of inflammatory changes, as 
contrast is needed to differentiate fluid from panus. MRI is 
also useful to estimate the treatment success (4,5). In a re-
cent systematic review, the diagnostic value of MRI for RA 
varied widely across studies, and in many studies MRI defini-
tions and scoring methods were not standardized (5). There 
are very few studies comparing prognostic and monitoring 
role of ultrasound (US) and MRI in RA (6).
Several studies confirmed the usefulness of US for the de-
tection of joint changes in RA and patients follow-up dur-
ing therapy, as well as for the guidance for intra-articular 
procedures (7). In a national survey of Spanish rheumatol-
ogists, the utility of US in the routine clinical practice was 
very high (7.8 at scale 0-10) in rheumatology in general, 
but particularly for the diagnosis and treatment decision 
making in RA (8). American College of Rheumatology re-
cently published a report on the reasonable use of US in 
rheumatology clinical practice (9). According to ACR/EU-
LAR criteria for the classification of RA, US examination is 
a valid method for detection of active synovitis (10) and it 
was even shown that US could detect activity in patients 
with clinical remission (11).
Gray-scale US enables accurate visualization of inflamed 
synovia, joint fluid, and paraarticular changes. Color and 
power Doppler are excellent for visualization of blood 
flow in inflamed joints, so that the stage of inflammatory 
changes can be estimated and the efficacy of treatment 
evaluated by analyzing the decrease in synovial thickening 
and reduction of vascularization (7-10,12). In patients with 
incipient RA changes, more erosions were diagnosed with 
US than with CR, and US provided a good estimate of the 
progression of early disease (13).
The aim of this study was to evaluate the role of gray-scale 
and color duplex Doppler ultrasound (CDUS) in diagno-
sis and follow-up of patients with RA during at least six-
months of treatment by comparing qualitative and quanti-
tative US parameters to several standard clinical indicators 
of the disease activity. The study design differed from pre-
vious studies because cut-off values of resistance index 
(RI), which might indicate the presence of active disease, 
were determined before and after the treatment. An ad-
ditional aim was to examine which hand joints should be 
examined and which could be omitted from the examina-
tion, thus reducing examination time. Finally, the examina-
tion performed in a highly-standardized fashion by a sin-
gle, experienced operator, using the top-quality scanner 
represented a rather exceptional setting for clinical studies 
about the utilization of CDUS in RA.
MaterIals and Methods
This prospective study consecutively included 30 patients 
with RA in whom adequate US exam could be performed 
on all joints (21 women and 9 men, age median 53 years, 
range 17-79) during one-month period in 2010. The pa-
tients with large deformities in whom US could not be 
properly performed were excluded. US examinations were 
performed at the baseline and after six months of treat-
ment on the day of clinical examination and disease activ-
ity score was determined. All patients were diagnosed and 
treated at the Department of Clinical Immunology and 
Rheumatology of University Hospital “Dubrava,” Zagreb, 
Croatia, and were recruited during routine diagnostic pro-
cedures. CR of both hands of each patient was performed 
to determine the stage of the disease and the presence 
of erosions, subluxations, or luxations that would pre-
vent the technical performance of the complete US exam. 
Gray-scale and CDUS were used to evaluate morphologic 
changes of inflamed joints, assess the degree of their vas-
cularization, quantify spectral changes, and assess effects 
of treatment. US findings were compared to clinical find-
ings and laboratory inflammatory parameters.
Examinations were performed on ulnocarpal (UC), meta-
carpophalangeal (MCP), and proximal interphalangeal 
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(PIP) joints at the baseline and after at least six-months of 
treatment (range 184-200 days in all patients; the total length 
of the study was 230 days encompassing the first and the last 
examination in all patients). Twenty-two joints of both hands 
(10 MCP, 10 PIP, 2 UC) were examined in each patient.
Twenty eight patients were treated with metothrexate 
in dosage ranging 17.5-25 mg/week and 2 patients with 
Arava (leflunomid) 20 mg every day. Among 28 patients 
treated with metothrexate, 8 patients were treated with 
anti-TNF-alpha inhibitors. Three were treated with Humira 
(adalimumab) 40 mg every second week subcutaneously, 
and 5 were treated with Enbrel (etanercept) 25 mg once 
a week subcutaneously. Twenty two patients who were 
treated with metothrexate or Arava, but not with biologics, 
were also treated with Salazopirin EN 500 (sulphasalazine) 
2 g per day. Among the latter, 14 patients were addition-
ally treated with glucocortcoids (metilprednisolone <10 
mg/d). Medical treatment was performed using standard 
and established dosages according to the established clin-
ical practice: all patients were treated by a single, experi-
enced clinical rheumatologist and immunologist with over 
20 years of experience (second author).
Rheumatoid factor (RF) and inflammatory parameters 
(erythrocyte sedimentation rate, ESR, and C-reactive pro-
tein, CRP) were measured at the baseline and after six 
months of treatment. The clinical Disease Activity Score 
– CRP in 28 joints (DAS 28), which is an indicator of the 
disease activity, was derived using the formula: DAS28 = 
0.56 × √TJ+0.28 × √SJ+0.36 × ln(CRP+1)+ 0.014 × GH+0.96, 
where TJ is the number of tender joints (0-28); SJ the num-
ber of swollen joints (0-28); GH general health scale or pa-
tients global assessment of disease activity (patients them-
selves estimate their condition on a 1-100 scale); and CRP 
C-reactive protein (14,15). Tender and swollen joint counts 
were determined in 28 joints that include shoulders, el-
bows, knees, wrists, MCP I-V joints, and PIP I-V joints. DAS 
28 values between 2.6 and 3.2 indicated low disease activ-
ity, between 3.2-5.1 moderate disease activity, and higher 
than 5.1 high disease activity. DAS 28 values below 2.6 in-
dicated remission.
Every patient completed the Health Assessment Question-
naire (HAQ), a self-administered standardized questionnaire 
about the individual daily functioning abilities (14,16). The 
questionnaire consists of 43 questions about the patient’s 
daily life functioning performance alone or with the help 
from another person concerning clothing, hygiene, 
standing, nutrition, walking, reaching for items, re-
ceiving items, opening of closed items, and small house-
hold chores. The questionnaire was translated to Croatian 
and previously validated. The answers are the following: 
without any difficulties – 0, difficult – 1, very difficult – 2, 
impossible – 3. The total final HAQ score is expressed as a 
mean value that is derived from the eight separate scores. 
The questionnaire also contains visual-analog scale for the 
estimation of pain and complete status (14,16).
US examinations of 22 UC, MCP, and PIP joints per patient 
were performed in a highly standardized fashion, using 
the high-performance ultrasound scanner Logiq 9 (Gener-
al Electric Medical Systems, Milwaukee, WI, USA), with the 
high frequency matrix probe (14 MHz). All examinations 
were performed by the first author, with fifteen years’ ex-
perience in the field of musculoskeletal US, on the same 
scanner with the same presets for each patient; the inter-
observer variability was not the issue in this study. All joints 
were examined from palmar and extensor sides. The right 
hand was examined first. Gray-scale was performed using 
the “compound mode” and “native harmonic” in standard 
dynamic interval with B-gain set at 2/3 of the maximum 
size. The presence of effusion, thickening of synovia, and 
joint erosions was estimated.
Findings were categorized semiquantitatively into four 
groups, according to Szkudlarek et al (17). The presence of 
joint effusion was categorized as: 0 – no fluid; 1 – minimal 
fluid; 2 – moderate fluid; 3 – large quantity of fluid; the syn-
ovial thickening as: 0 – no synovial thickening; 1 – minimal 
synovial thickening; 2 – synovial thickening that exceeds 
the line connecting periarticular bones, without extension 
to the bone dyaphisis; 3 – synovial thickening that exceeds 
the line which connects periarticular bones and also ex-
tends on dyaphisis; and bone changes as: 0 – regular bone 
surface, 1 – irregular bone surface, 2 – small defect on bone 
surface, 3 – defect on bone surface with destruction.
Color Doppler (CD) was used to estimate the degree of 
vascularization of the inflamed synovia. Technical param-
eters were always the same to enable accurate compari-
son of the results. The lowest wall-filter that eliminated ves-
sel wall noise was used, color gain was set at the 2/3 of 
the maximum value, the lowest pulse repetition frequen-
cy was used that does not cause aliasing, and the priority 
level was set at 90% so that the slow flow in small vessels 
could be visualized. Angle correction was performed care-
fully, as this is crucial for obtaining accurate values. The sin-
gle color scale with red-orange-yellow shades was always 
used. CD findings were categorized into four groups: 0 – 
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no vascularization, 1 – color signal in only one blood vessel, 
2 – more color signals in vessels, but on the surface that is 
smaller than the half of the complete size of the synovia, 3 
– more signals in vessels on the surface larger than the half 
of the synovial size (17) (Figures 1-3).
In the joints where vascularization was observed, the quan-
titative values were measured using the spectral frequency 
analysis of arterial flow: peak systolic velocity (PSV), end di-
astolic velocity (EDV), and RI. Altogether 1320 joints in 30 
patients were examined by US, 660 joints at baseline and 
the same joints after six months of therapy.
Clinical and laboratory parameters – RF, CRP, ESR, DAS 28, 
and HAQ values – were determined on the day of the first 
US examination and again after at least six months of treat-
ment, at the time when the patients were reexamined by 
US. Results were compared with the gray-scale findings 
and with the qualitative and quantitative CDUS param-
eters. The validity of diagnostic procedure was calculated 
for different cut-off values of RI that were arbitrarily deter-
mined (RI 0.40; RI 0.45; RI 0.50; RI 0.55) for the groups be-
fore and after therapy in relation to DAS28 score of >3.2 
to determine the best cut-off values of RI indicating active 
disease before the treatment and successful treatment in 
the post-treatment group of patients. All patients signed 
informed consent and the research was approved by the 
Ethics Committees of the Institution (University Hospital) 
and of the University of Zagreb School of Medicine.
statistical analysis
The variables were analyzed using descriptive measures. 
Quantitative variables distribution was tested by Kolmog-
orov-Smirnov test. Variables with normal distribution were 
analyzed with paired samples t test and Pearson correla-
FIGure 1. Vascularization in ulnocarpal joint – group 1: dop-
pler color signal in only one blood vessel.
FIGure 2. Vascularization in ulnocarpal joint – group 2: more 
doppler signals in vessels, but on the surface that is smaller 
than the half of the complete size of synovia.
FIGure 3. Vascularization in ulnocarpal joint – group 3: more 
doppler signals in vessels on the surface larger than the half of 
the synovial size.
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tion analysis and variables with not-normal distribution 
with Wilcoxon’s test of equivalent pairs and Spearman’s 
correlation analysis. Qualitative variables and dependent 
samples were tested with χ˛-test, Stuart-Maxwell’s test, and 
McNemar’s test. Measures of diagnostic procedure validity 
were determined (sensitivity, specificity, positive predictive 
value, negative predictive value, and accuracy). Statistical 
analysis was performed using STATISTICA, ver. 10 (StatSoft 
Inc., Tulsa, OK, USA). The level of statistical significance was 
set at P < 0.05.
results
Changes of laboratory parameters, das 28 and haQ
ESR, DAS 28, and HAQ score significantly decreased after 
treatment compared to the baseline values (P = 0.013, 
P < 0.001, P = 0.030, respectively, t test for sample pairs); 
changes of HAQ and DAS 28 scores indicated suc-
cessful treatment as the disease activity was reduced. RF 
values also decreased significantly, while CRP decreased 
but not significantly (P = 0.015 and P = 0.061, respectively, 
Wilcoxon’s test of equivalent pairs) (Table 1).
Changes of qualitative sonographic parameters: 
erosions, synovial thickening, synovial effusions, and 
vascularization
Erosions, synovial thickening, and synovial effusions were 
evaluated by gray-scale US. The number and the degree 
of joint erosions did not change significantly between 
baseline and the end of treatment. Synovial thicken-
ing was significantly reduced in 7 out of 12 MCP and UC 
joints, synovial effusion in 2 MCP joints, and vasculariza-
tion, estimated by CDUS, in one UC and one MCP joint 
(Table 2).
Changes of quantitative doppler parameters
Quantitative spectral parameters of PSV, EDV, and RI were 
measured by CDUS. After treatment RI increased signifi-
cantly in 4 joints, as indicator of successful treatment. PSV 
decreased significantly in 3 joints and EDV decreased sig-
nificantly in 5 joints (paired sample t test) (Table 3). The ul-
trasonographic changes of quantitative parameters in a 
single patient are presented in Figure 4.
In PIP joints, the differences between baseline and af-
ter therapy were not significant. These joints are smaller, 
and on baseline examination no pathologic changes were 
observed on gray-scale (erosions, synovial thickening, ef-
fusions) or CD (vascularization) in 50%-97% of PIP joints. 
Since in most PIP joints increased vascularization could not 
be demonstrated initially it was impossible to determine 
PSV, EDV, and RI. The only PIP joint with a significant dif-
ference in EDV was the left PIP III, in which EDV decreased 
from 5.52 ± 0.12 cm/s to 2.74 ± 0.00 cm/s after therapy 
(paired sample t test, P = 0.019).
taBle 1. Baseline and post-treatment levels of erythrocyte sedimentation rate (esr), disease activity score (das 28), health assess-
ment Questionnaire (haQ), rheumatoid factor (rF), and C reactive protein (CrP)
Baseline level Post-treatment level/average P
ESR (mm/h) (mean ± standard deviation) 38.1 ± 22.4 27.8 ± 20.9 0.013*
DAS28 (mean ± standard deviation) 5.47 ± 1.56 3.87 ± 1.65 <0.001*
HAQ (mean ± standard deviation 1.26 ± 0.66 0.92 ± 0.74 0.030*
RF (IU/mL) (median, range) 202.75 (2.1-1205.0) 104.25 (1.0-443.0) 0.015†
CRP (mg/L) (median, range)  31.65 (0.70-124.5)  22.8 (0.30-107.2) 0.061†
*t test for sample pairs.
†Wilcoxon’s test of equivalent pairs.
taBle 2. Changes of qualitative ultrasonographic parameters 
of synovial thickening, effusions, and degree of vascularization, 
which were significant after treatment on different joints
Joint P value (stuart Maxwell-test)
synovial thickness
UC L 0.046
MCP 1 R 0.046
MCP 1 L 0.020
MCP 3 R 0.024
MCP 4 L 0.012
MCP 5 R 0.018
MCP 5 L 0.009
Effusions
MCP 1 R 0.035
MCP 2 L 0.044
Vascularization degree
UC R 0.002
MCP 3 R 0.024
*uC – ulnocarpal; MCP – metacarpophalangeal; r – right; l – left.
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Changes of qualitative and quantitative us variables in 
MCP and uC joints
After therapy, 12 MCP and UC joints showed significant 
differences in all US qualitative and quantitative variables 
(Table 4). In 12 joints there was a significant change in at 
least one parameter. In 6 out of 12 joints, significant chang-
es were observed in 2 or more parameters. In 2 UC joints, 
changes were observed in 3 or more parameters. Interest-
ingly changes were much more numerous on the joints of 
the right hand (14 vs 8).
The relation between RI and clinical activity DAS 28 score 
of >3.2 was investigated by testing the validity of differ-
ent cut-off RI values for patients before and after therapy. 
In the “before treatment group,” the best indicators were 
found for the cut-off value of RI<0.40 with the sensitivity, 
specificity, positive predictive value, and negative predic-
FIGure 4. (A) example of increased vascularization of the group 2 in the left ulnocarpal joint with spectrum indicated inflammation 
and low resistance index (rI) of 0.51. (B) the same left ulnocarpal joint after treatment demonstrated a decrease in vascularization 
and now can be classified as group 1, with rI value of 0.69
taBle 3. Quantitative doppler spectral parameters at baseline and after treatment (mean ± standard deviation)
Joint Baseline six months P (t test for sample pairs)
resistance index
UC R 0.51 ± 0.10 0.60 ± 0.10 0.002
UC L 0.49 ± 0.08 0.61 ± 0.11 0.001
MCP 3R 0.46 ± 0.09 0.61 ± 0.12 0.003
MCP 5 R 0.49 ± 0.10 0.62 ± 0.10 0.042
Peak systolic velocity in cm/s
UC R 7.37 ± 3.31 5.92 ± 3.16 0.049
MCP 2 R 9.78 ± 5.82 8.98 ± 5.98 0.040
MCP 4 R 7.75 ± 2.18 6.56 ± 2.12 0.017
end-diastolic velocity in cm/s
UC R 3.54 ± 1.86 2.26 ± 1.11 0.002
UC L 3.71 ± 1.44 2.28 ± 1.19 0.001
MCP 3 R 3.81 ± 1.58 2.48 ± 1.75 0.033
MCP 3 L 4.65 ± 1.42 3.28 ± 1.85 0.032
MCP 4 R 3.75 ± 1.08 2.65 ± 0.98 0.025
*uC – ulnocarpal; MCP – metacarpophalangeal; r – right; l – left.
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tive value of 100%. In the “post-treatment group,” the best 
indicators were found for the cut-off value of RI≥0.55, with 
the sensitivity of 100%, specificity of 87%, positive predic-
tive value of 94%, and negative predictive value of 100%.
dIsCussIon
This study confirmed that US of UC and MCP joints was 
useful in diagnosis and treatment of RA and that quantita-
tive Doppler parameters provided important information 
about disease activity and treatment efficacy.
It is difficult to predict the course of RA in an individual 
patient. Most patients have active disease but with consid-
erable intensity fluctuations, resulting in different degree 
of joint disorder and functional damage (1). Therapy rare-
ly completely inhibits bone erosions, and the absence of 
the erosion progression is a good indicator of an effective 
treatment (3). We did not observe significant sonograph-
ic changes in the stage of bone erosions after treatment, 
which indicates that US monitoring of erosions is not clini-
cally relevant, at least in a relatively short six-month follow-
up period.
Several studies have shown that gray-scale and CDUS 
demonstrated inflammatory changes in patients with RA, 
estimated the extent of the joint disease, and evaluated 
changes after medical therapy (7-14). Some studies have 
shown that US can evaluate the effects of tumor necrosis 
factor alpha-antagonist drugs treatment in patients with 
RA (12,18-23). Recently it has even been shown that RA pa-
tients in clinical remission and with US-defined active syn-
ovitis exhibited higher disease activity and increased se-
rum levels of angiogenic biomarkes (24).
Most US studies in RA so far have been performed on small 
joints of hands and fingers, but examinations are expand-
ing to larger joints as well, like in a study that recently eval-
uated US score for large joints (shoulder, elbow, hip, knee), 
the so called SOLAR score (sonography of large joints in 
rheumatology) (25). Moreover, Ribbens (12) and Terslev 
(26) noted that Doppler spectral analysis had the potential 
to estimate inflammation in RA.
The strength of this study is that it evaluated a large num-
ber of gray-scale and CDUS features on a large number of 
hand joints in a highly-standardized fashion, by a single 
physician. However, the number of patients was small, only 
thirty, which is the major weakness of the study.
Synovial thickening was significantly reduced after ther-
apy in 7 of 12 MCP and UC joints, and this seems to be 
the most important morphologic gray-scale feature that 
should be evaluated in patients with RA, rather than effu-
sions or erosions.
Inflammatory hyperemia is visualized on CDUS as hyper-
vascularization (higher number of small blood vessels with 
detectable slow flow) and decreased RI on spectral analy-
sis. Decreased RI is the consequence of increased diastolic 
flow due to reduced resistance and vasodilatation during 
inflammatory hyperemia. Reduced flow velocity, reduced 
level of vascularization, elevated RI in treated patients, and 
correlation between qualitative (vascularization level) and 
taBle 4. distribution of significant changes of qualitative and quantitative ultrasonographic variables after treatment in MCP and uC 
joints of both hands*
Joint synovial thickening effusions Vascularization rI PsV edV
UC R ↓ ↑ ↓ ↓
UC L ↓ ↑ ↓
MCP1 R ↓ ↓
MCP1 L ↓
MCP2 R ↓
MCP2 L ↓
MCP3 R ↓ ↓ ↑ ↓
MCP3 L ↓
MCP4 R ↓ ↓
MCP4 L ↓
MCP5 R ↓ ↑
MCP5 L ↓
*UC – ulnocarpal; MCP – metacarpophalangeal; R – right; L – left; RI – resistance index; PSV – peak systolic velocity; EDV – end-diastolic velocity; 
↓ – statistically significant decrease; ↑ – statistically significant increase.
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quantitative (RI, PSV, EDV) Doppler parameters and clini-
cal stage of disease (DAS 28) could have major clinical im-
plications. We demonstrated that CDUS features could be 
analyzed in MCP and UC joints, and that successful treat-
ment results in the reduction of velocities and RI increase. 
Changes in quantitative Doppler parameters were ob-
served in both UC joints and in 5/10 MCP joints. Our results 
indicate that RI<0.40 could be a useful threshold value to 
diagnose clinically active disease, while RI of 0.55 and high-
er could indicate successful treatment results. However, we 
used a highly-selected group of patients with pronounced 
clinical signs of active disease on the initial examination, 
and cut-off values were determined for patients with mod-
erate disease activity who had DAS 28 score >3.2. Our re-
sults are in accordance with those by Terslev et al (26) and 
Varsamidis et al (27), who demonstrated that hand-joint 
changes may be quantified with Doppler and that RI in-
creased during therapy.
Qualitative and quantitative Doppler parameters reflect 
the stage of inflammatory hyperemia and provide the 
information that cannot be obtained with CR. CR can-
not demonstrate or quantify vascularization, but only the 
changes on joint surfaces that are the consequence of in-
flammation. On the other hand, scintigraphy and MRI in-
directly show inflammatory activity but cannot quantify 
it. US has considerable advantages to other imaging mo-
dalities, since it is noninvasive, does not expose patients 
to radiation, does not require injection of contrast media, 
and is widely available and cheap. Utilization of qualitative 
and quantitative US parameters during treatment could 
be a convenient noninvasive way to estimate the effec-
tiveness of therapy. CDUS examination should therefore 
be part of the follow-up algorithm for patients with RA 
during treatment.
No significant differences between baseline and end of 
therapy were observed on PIP joints, with only one joint as 
exception. It is quite hard to visualize vascularization with 
CD, ie, to demonstrate Doppler signal in these small joints, 
which is a prerequisite for evaluation of quantitative spec-
tral parameters. Therefore, due to time-consuming and dif-
ficult examination, PIP joints can be omitted from studies 
that evaluate treatment efficacy in RA, which is an impor-
tant finding of this study.
More significant changes were observed on the right than 
on the left hand, maybe because the right hand was exam-
ined first and as the time passed the examiner got less pre-
cise. Further studies are needed to address this issue and 
investigate if this finding might be related to the fact that 
the right hand is used more by right-handed people.
For the accurate estimate of the treatment efficacy, the pa-
tient has to be examined in a similar fashion before and af-
ter therapy. In our study, US examinations were performed 
in a highly standardized fashion. The quality of image and 
sensitivity of vascularization detection with Doppler de-
pends on a quality of the scanner, and patients’ findings 
may differ considerably if they are examined on different 
scanners or using different gray-scale and Doppler settings 
on the same scanner. In US studies, the experience of the 
examiner is crucial. In this study, in order to eliminate or 
reduce errors all patients were examined before and af-
ter treatment on the same high quality state-of-art ultra-
sound scanner with the same, high quality high-frequency 
transducer, with similar settings and scanning parameters 
(gain, electronic focusing, dynamic range) by a single ex-
aminer. However, all this is not feasible in daily clinical prac-
tice. It requires time, high quality scanners, and maximum 
concentration of the examiner. An experienced examiner 
needs some 60 minutes to examine 22 joints of every pa-
tient and to perform all the necessary measurements. Our 
results, however, indicate that 10 PIP joints can be exclud-
ed from the examination protocol, which considerably re-
duces examination time and makes CDUS more feasible in 
daily clinical practice. This is in accordance with the recent 
studies by Naredo et al (28), who proposed 12-joint evalu-
ation and Perricione et al (21), who proposed 6-joint evalu-
ation for joint inflammation in RA (wrist, second MCP, and 
knee), and another study by Naredo et al who proposed 
wrist, ankle, and MTP joint assessment for detecting resid-
ual gray scale and Doppler joint inflammation (29).
US-estimated alterations are partly quantifiable and can be 
compared to the patient’s clinical state and indicators of dis-
ease activity. Contrast-enhanced US may provide even bet-
ter sensitivity for detection of abnormal vascularization and 
quantification of changes during treatment. A drawback of 
this study is that many patients considered to be in clinical 
remission according to the DAS and ACR/EULAR definitions 
may still have residual synovitis on US, which makes prog-
nostic significance of US findings debatable (30).
In conclusion, gray scale and CDUS are useful to detect 
changes on hand joints in patients with RA and to moni-
tor the effectiveness of the therapy. US parameters high-
ly correlate with the laboratory and clinical indicators of 
disease activity. Reduction of synovial thickening is the 
best gray scale indicator of treatment efficacy, while 
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Doppler findings that correlate with clinical improvement 
are decreased vascularization, accompanied by elevation 
of RI, and decrease in PSV and EDV. The novelty of this re-
search is that it demonstrated the importance of quantita-
tive Doppler parameters and that it found that the cut-off 
values of RI of 0.40 at baseline and 0.55 after the treatment 
indicated the presence of active disease and the efficacy 
of treatment, respectively. We found that only UC and MCP 
joints should be examined, while PIP joints can be omitted 
from examination protocol, which is an important finding 
for the clinical utilization of CDUS in RA.
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